#NIHRECOVER Adult is a cohort study of ~15k adults with/without #COVID, followed prospectively. They answer symptom surveys every 3 months and do additional tests yearly. 93% of cohort has been enrolled; this paper includes 9,764 participants. recovercovid.org
Main goal of this paper is to establish an expanded, working symptom-based definition of #LongCOVID for research purposes. Please note we do not propose this as a clinical definition right now pending further validation & refinement.
Methods: we studied symptoms reported 6 months or later (for those who enroll >6 months after infection) after infection. Main analysis uses all symptoms, whether present pre-COVID or not. Sensitivity analysis used just new symptoms.
Methods: symptom survey has 44 symptoms. We included 37 with frequency >2.5% in cohort, restricting to >=moderate severity where possible. We used balancing weights (by age/sex/race/ethnicity) to match uninfected and infected participants.
First, we assessed each symptom to see which were more common in infected vs uninfected participants. Result: all of them! But some much more than others. Note also that some common symptoms have lower OR because also common in uninfected (e.g. fatigue, 38% vs. 17%).
Most studies stop here. But these symptoms, while more common in infected, happen in uninfected too. So just having a symptom is not enough for a reliable research definition. We decided to look for a SET of symptoms that collectively would be rare to find in uninfected.
We fit a LASSO model using 10-fold cross-validation and class weighting, with the 37 symptoms as predictors, infection as outcome. That method helps us select symptoms that best distinguish between infected/uninfected, and it got us down to just 12 symptoms.
📷
IMPORTANT: these are not the ONLY symptoms that people have, nor are they necessarily the most important to patients, the most common, the most severe or most burdensome. They are just the symptoms that are the most useful in trying to decide who might have #LongCOVID.
Then, we took the coefficients of this model, multiplied each by 10 and rounded them to turn each coefficient into nice, tidy integer points. For each participant, we added up all their points to generate a total score.
Now, the tricky part. What total score is reasonable to call #LongCOVID? There is no “right” answer. We used 10-fold cross-validation to identify an optimal threshold that minimized misclassification of uninfected while capturing infected.
Our optimal threshold was score of 12. At this cutoff, only 4% of uninfected are misclassified as having #LongCOVID. (Note, it is also possible that some of our “uninfected” had occult infection; we check antibodies but those do wane.)
For some face validity, we noted that the higher the score, the worse the quality of life, general physical health, and ability to carry out everyday physical activities: as expected.
Now, we are cooking with gas. With #LongCOVID definition in hand, we could take a quick, early look at interesting questions that we will revisit later with more rigor.
For instance, what is prevalence of #LongCOVID? We find it to be 10% @6 months in “acutes” enrolled <30 days from infection (least biased – enrolled prior to knowing if they have #LongCOVID). Note, they all had Omicron and are almost all vaccinated.
What is recovery like? 1/3 of people who met #LongCOVID definition at 6 months no longer met it at 9 months; not likely just random variation around threshold because reverse is only 7% (no at 6 mo/yes at 9 mo).
Does vaccination reduce risk? At first glance, yes. We didn't do a formal analysis; that will come in future.
What about reinfection? Hard to say, small Ns. Maybe a risk. Will look at this properly in future.
Is #LongCOVID a collection of different syndromes? We did a cluster analysis and found 4 clusters that had some differences but not dramatically different profiles. BUT, score requires symptoms in multiple domains, so this could be artifact of definition.
Want to participate in generating more science like this? We have reserved the last few slots in the adult cohort for people living in rural areas or who identify as Hispanic. If you meet these criteria and are interested, check out recovercovid.org to volunteer.
@atitapatterns@A_E_Urdaneta@zach_wallace_md; & a ton of non-Twitter authors including senior author Andrea Foulkes. If you have a common name and I couldn't find you feel free to add yourself!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Have been too busy enjoying seeing people in person and seeing so much great research at #SGIM22 to have been tweeting, but what a great meeting. @nyugrossman was out in force /1
Med student Kyle Smith had a wonderful oral presentation on how we have developed a method of finding people on oral anti psychotics who haven’t had a1c testing (no pics cause I was so busy watching!) with @SaulBlecker /2
T32 trainee Rachel Engelberg had a great poster on incarceration and health outcomes /3
Fascinating article about how research into types and efficacy of traffic stops in multiple CT communities led to changes that both reduced disparities in stops and better targeted actual public safety issues. Some examples follow:
In Newington, 40% (1,608) traffic stops were for defective lights but found only 1 DUI. Dept switched focus to moving violations (defective lights ⬇️67%, moving violations ⬆️60%). Stops with DUI arrest ⬆️250%, from 18 to 63, and disparities substantially reduced: safer & fairer!
Hamden tried increasing stops for admin issues (lights, registration) to reduce crime in Black neighborhood but rarely found contraband (7%), no effect on crime, caused huge disparities. Switched to stops for hazardous driving: crime ⬇️5%, accidents ⬇️10%, found more contraband.
A lot of chatter about hospitalization "with" versus "for" COVID, implying current hospitalization wave isn't "real." NY state is going to start trying to report the distinction; UK already does. Some thoughts, with exemplar data. /1
1st, not so easy to tell. Our health system calls "for" COVID: patients with problem list or clinical impression of respiratory failure with hypoxia (various codes), or x "due to COVID" or COVID positive is the only problem. Specific, but likely not very sensitive. /2
That is, people who meet those criteria are very likely being admitted for COVID, but others will be missed (e.g. diagnosis pneumonia, sepsis, COVID-related stroke/heart attack/PE). So, likely an underestimate. Still, if used consistently, may be useful approximation. /3
Phenomenal preprint from South Africa on #omicron severity. Insanely fast analysis with multiple linked national datasets. Kudos to the authors. Results? You'll see headlines about reduced severity, but full story more complicated. My thoughts. medrxiv.org/content/10.110…
First off, methods. They link lab tests, case data, genome data and hospital data from across all of South Africa. (Wow!) They use a proxy for omicron (SFTF) and require Ct <=30 ("real" infection).
Then they run two comparisons: omicron vs not omicron Oct-Nov, and omicron Oct-Nov vs delta Apr-Nov, and compre frequency of hospitalization and of severe disease (=hospitalised + any of ICU/O2/ventilated/ECMO/ARDS/death). Outcomes assessed on 21 Dec (day preprint posted?!).
Incomplete article in the @nytimes today re: vaccine effectiveness made me finally read last week's NEJM letter suggesting more waning of Moderna than NYT suggests. Will walk you through it. /1 nejm.org/doi/full/10.10…
This reports data from a Moderna randomized trial, in which 14,746 people got vaccine Jul-Dec 2020 and 11,431 got placebo. The placebo group then got the real vaccine later, between Dec 2020-Apr 2021. /2
In Jul-Dec 2020 the vaxxed group had way lower infections than the placebo group (11.8 per 1000 person-years vs. 148.8 cases per 1000 person-years); that's of course why the vaccine got approved. May-June '21, once the placebo group vaccinated, rates were equal. But... /3
Took a Twitter break for several months to help get @NIH#RecoverCOVID up and running to study #LongCovid (AKA #PASC). Thrilled to report @UTHealthSA@UHHospitals have enrolled our first 7 participants! Congrats to them and cast of 1000s working night and day to kick it off. /1
#RecoverCOVID will follow >17K adults, >20K kids across nation + PR for 4 yrs to learn what #LongCovid looks like, how long it lasts, what causes it/increases risk, and, ultimately, what makes it better. Will also include autopsy data and electronic health records of millions. /2
You can find out more about it here recovercovid.org and can sign up to be told more about enrollment opportunities. /3